BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2280614)

  • 1. Early protooncogene expression during hemin-induced differentiation of human erythroleukemic cells.
    Griffin MO; Nelson JC; Abraham NG
    Leuk Res; 1990; 14(11-12):997-1006. PubMed ID: 2280614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in gene expression associated with induced differentiation of erythroleukemia: protooncogenes, globin genes, and cell division.
    Ramsay RG; Ikeda K; Rifkind RA; Marks PA
    Proc Natl Acad Sci U S A; 1986 Sep; 83(18):6849-53. PubMed ID: 3462732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired erythroid-specific gene expression in cAMP-dependent protein kinase-deficient murine erythroleukemia cells.
    Pilz RB
    J Biol Chem; 1993 Sep; 268(27):20252-8. PubMed ID: 8376386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of differentiation in Friend-erythroleukemia cells by aclacinomycin A: early transient decrease in c-myc and c-myb mRNA levels.
    Schaefer A; Dressel A; Lingelbach K; Schmidt CA; Steinheider G; Marquardt H
    Leukemia; 1992 Aug; 6(8):828-33. PubMed ID: 1640736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulated expression of the c-myb and c-myc oncogenes during erythroid differentiation.
    Kirsch IR; Bertness V; Silver J; Hollis GF
    J Cell Biochem; 1986; 32(1):11-21. PubMed ID: 3464612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth-inhibition by hemin in K562 human leukemic cells is related to hemoglobin-producing activity.
    Sasaki D; Kosunago S; Mikami T; Matsumoto T; Suzuki M
    Biol Pharm Bull; 1994 May; 17(5):586-90. PubMed ID: 7920413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-myb but not c-myc suppresses the hemin-induced nonterminal expression of hemoglobin by murine erythroleukemia cells.
    Prochownik EV
    Blood; 1989 Feb; 73(3):782-6. PubMed ID: 2644989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of globin gene induction in single human erythroleukemic cells.
    Smith RD; Malley JD; Schechter AN
    Nucleic Acids Res; 2000 Dec; 28(24):4998-5004. PubMed ID: 11121491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium ionophore-induced transient down-regulation of c-myb mRNA levels in Friend erythroleukemia cells.
    Schaefer A; Stöcker U; Marquardt H
    J Biol Chem; 1993 May; 268(15):10876-80. PubMed ID: 8496152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of transformed cells to terminal differentiation.
    Marks PA; Sheffery M; Ramsay R; Ikeda K; Rifkind RA
    Ann N Y Acad Sci; 1987; 511():246-55. PubMed ID: 3326466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of c-myc proto-oncogene during podophyllotoxin induced IW32 erythroleukemia cell differentiation.
    Yen YT; Wu RT; Tang SJ; Wang FF
    Biochem Biophys Res Commun; 1991 Sep; 179(3):1241-6. PubMed ID: 1930169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of protooncogenes c-myb and c-myc during the hexamethylene bisacetamide (HMBA)-induced commitment to terminal differentiation of murine erythroleukemia cells].
    Chen ZX
    Zhonghua Zhong Liu Za Zhi; 1991 Jul; 13(4):261-4. PubMed ID: 1806345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ca2+/calmodulin-dependent and -independent down-regulation of c-myb mRNA levels in erythropoietin-responsive murine erythroleukemia cells. The role of calcineurin.
    Schaefer A; Magócsi M; Stöcker U; Fandrich A; Marquardt H
    J Biol Chem; 1996 Jun; 271(23):13484-90. PubMed ID: 8662717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tiazofurin on globin and proto-oncogene expression in K562 erythroleukemia cells.
    Kharbanda SM; Miyazaki K; Takeyama H; Sherman ML; Spriggs DR; Carney WP; Kufe DW
    Cancer Commun; 1989; 1(3):191-7. PubMed ID: 2639729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continued withdrawal from the cell cycle and regulation of cellular genes in mouse erythroleukemia cells blocked in differentiation by the c-myc oncogene.
    Coppola JA; Parker JM; Schuler GD; Cole MD
    Mol Cell Biol; 1989 Apr; 9(4):1714-20. PubMed ID: 2657403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential expression of proto-oncogenes during a mouse erythroleukemia cell differentiation.
    Todokoro K; Ikawa Y
    Biochem Biophys Res Commun; 1986 Mar; 135(3):1112-8. PubMed ID: 3457564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In K562 leukemia cells treated with doxorubicin and hemin, a decrease in c-myc mRNA expression correlates with loss of self-renewal capability but not with erythroid differentiation.
    Toffoli G; Viel A; Bevilacqua C; Maestro R; Tumiotto L; Boiocchi M
    Leuk Res; 1989; 13(4):279-87. PubMed ID: 2654492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-myc and c-myb oncoproteins during induced maturation of myeloid and erythroid human leukemic cell lines.
    Pedrazzoli P; Bains MA; Watson R; Fisher J; Hoy TG; Jacobs A
    Cancer Res; 1989 Dec; 49(24 Pt 1):6911-6. PubMed ID: 2684403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced erythroleukemia differentiation: cellular and molecular aspects.
    Rifkind RA; Sheffery M; Marks PA
    Blood Cells; 1987; 13(1-2):277-84. PubMed ID: 3311222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in gene expression during hexamethylene bisacetamide induced erythroleukemia differentiation.
    Marks PA; Ramsay R; Sheffery M; Rifkind RA
    Prog Clin Biol Res; 1987; 251():253-68. PubMed ID: 3481077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.